$310.53
Value $838B
JPM and NMR stock compared: price, dividend, valuation and results, from SEC filings.
$310.53
Value $838B
$8.51
Value $25.0B
JP Morgan Chase & Co. (JPM) has a market value of $838B and Nomura (NMR) $25.0B. Over the last year, with dividends, JPM moved +4.4% and NMR +21.7%. The P/E is 13.0 for JPM and 11.0 for NMR. Dividend yield: JPM 1.98%, NMR none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
JPM$838B
NMR$25.0B
JPM is 33 times NMR
Revenue, 12 months
JPM$203B
NMR$13.6B
JPM is 15 times NMR
Net income, 12 months
JPM$66.0B
NMR$2.3B
JPM is 29 times NMR
Operating margin
JPM–
NMR–
ROIC
JPM15.1%
NMR2.0%
13.1 points apart
P/E
JPM13.0
NMR11.0
JPM is 1.2 times NMR
Dividend yield
JPM2.0%
NMR0.0%
2.0 points apart
5-year return
JPM+118.6%
NMR+117.3%
1.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
JPM+118.6%
NMR+117.3%
| Period | JPMWith dividends | NMRWith dividends |
|---|---|---|
| 1 year since November 19, 2025 | +4.4%Price +2.4% | +21.7%Price +21.7% |
| 3 years since November 20, 2023 | +115.9%+29.2% a yearPrice +102.6% | +119.9%+30.0% a yearPrice +102.6% |
| 5 years since November 19, 2021 | +118.6%+16.9% a yearPrice +93.0% | +117.3%+16.8% a yearPrice +100.2% |
| 10 years since November 21, 2016 | +416.3%+17.8% a yearPrice +297.9% | +72.4%+5.6% a yearPrice +57.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
JPMJP Morgan Chase & Co.NMRNomura
| Price | $310.53 | $8.51 |
|---|---|---|
| Market value | $838B | $25.0B |
| Enterprise value (EV) | – | – |
| P/E | 13.0 | 11.0 |
| P/E, 5-year median | 11.1 | 11.3 |
| P/B | 2.4 | 1.1 |
| EV/EBIT | – | – |
| Free cash flow yield | – | – |
| Revenue, 12 months | $203B | $13.6B |
|---|---|---|
| Net income, 12 months | $66.0B | $2.3B |
| Free cash flow, 12 months | – | – |
| Earnings per share, 12 months | $23.85 | $0.75 |
| Revenue growth, year on year | 2.8% | 14.5% |
| Revenue growth a year, past | +8.8%over 5 years | +9.1%over 5 years |
| EPS growth a year, past | +17.7%over 5 years | +19.6%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 32.5% | 16.7% |
| ROIC | 15.1% | 2.0% |
| ROE | 18.0% | 9.8% |
| Cash | $1.11T | $27.0B |
|---|---|---|
| Total debt | $531B | $17.30T |
| Net debt / EBITDA | – | – |
| Interest cover | – | – |
| Dividend yield | 2.0% | – |
|---|---|---|
| Dividend per share, 12 months | $6.15 | – |
| Dividend growth a year, past | +10.0%over 5 years | – |
| Buyback yield | 3.8% | 2.6% |
| Shareholder yield | 5.8% | 2.6% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, JP Morgan Chase & Co. ($838B) is about 33.4 times Nomura ($25.0B), at today's prices.
Since November 21, 2016, JPM's price moved +297.9% and NMR's +57.3%. With dividends: JPM +416.3% (+17.8% a year), NMR +72.4% (+5.6% a year). Past returns do not predict future ones.
The dividend yield at today's price is 1.98% for JP Morgan Chase & Co. and none for Nomura. Over the last twelve months they paid $6.15 and – per share.
At today's price, the P/E is 13.0 for JPM and 11.0 for NMR. The median of the last five years was 11.1 and 11.3, which shows where each stands against its own past.
Over the last twelve months, the net margin was 32.5% for JP Morgan Chase & Co. and 16.7% for Nomura, and the operating margin – and –. Revenue was $203B and $13.6B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.